Rosalind Advisors, Inc. 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 249,092 9.900% | 16,744 (+7.21%) | Filing |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 232,348 9.900% | 99,261 (+74.58%) | Filing |
| 2024-07-11 5:37 pm Unchanged | 2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 133,086 9.900% | 0 (Unchanged) | Filing |
| 2024-04-25 8:01 pm Sale | 2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 133,086 9.900% | -89,478 (-40.20%) | Filing |
| 2024-02-14 8:31 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 222,564 9.900% | 150,622 (+209.36%) | Filing |
| 2023-02-13 5:53 pm Unchanged | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 71,942 9.970% | 0 (Unchanged) | Filing |
| 2022-11-02 8:03 pm Purchase | 2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 71,942 9.970% | 51,768 (+256.60%) | Filing |
| 2022-01-21 3:49 pm Purchase | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 20,174 9.970% | 9,484 (+88.71%) | Filing |
| 2021-07-08 1:30 pm Purchase | 2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 10,691 6.000% | 10,691 (New Position) | Filing |